Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model. (Q48782929)
Jump to navigation
Jump to search
scientific article published on 27 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model. |
scientific article published on 27 April 2016 |
Statements
1 reference
Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model. (English)
1 reference
Liqin Qi
1 reference
Linfang Ke
1 reference
Xiaohong Liu
1 reference
Lianming Liao
1 reference
Sujie Ke
1 reference
Xiaoying Liu
1 reference
Yanping Wang
1 reference
Xiaowei Lin
1 reference
Yu Zhou
1 reference
Lijuan Wu
1 reference
Zhou Chen
1 reference
Libin Liu
1 reference
27 April 2016
1 reference
1 reference
783
1 reference
23-32
1 reference
Identifiers
1 reference
1 reference